Download presentation
Presentation is loading. Please wait.
Published byCharity Lynch Modified over 9 years ago
1
Alterations of Leukocyte, Lymphoid, and Hemostatic Function Chapter 27 Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
2
2 Alterations of Leukocyte Function Deficiencies in the quality and quantity of leukocytes (leukopenia) Increased numbers of leukocytes (leukocytosis) Many hematologic disorders are malignancies Many nonhematologic malignancies metastasize to bone marrow, affecting leukocyte production
3
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 3 Alterations of Leukocyte Function Quantitative disorders Increases or decreases in cell numbers Bone marrow disorders or premature destruction of cells Response to infectious microorganism invasion Qualitative disorders Disruption of cellular function
4
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 4 Quantitative Alterations of Leukocytes Leukocytosis Counts higher than normal Leukocytosis is a normal protective physiologic response to stressors Leukopenia Counts lower than normal Leukopenia is always abnormal Low WBC count predisposes to infections
5
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 5 Granulocytosis (Neutrophilia) Evident in first stages of infection/inflammation If need for neutrophils increases beyond the supply, immature neutrophils (banded neutrophils) released into the blood Premature release detected in manual WBC differential and is termed a shift to the left Leukemoid reaction When the population returns to normal, it is termed a shift to the right
6
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 6 Neutropenia Reduction in circulating neutrophils Primary Congenital Congenital Cyclic neutropenia and neutropenia with congenital immunodeficiency diseases Multiple syndromes Acquired Acquired Multiple conditions (hypoplastic anemia, aplastic anemia, leukemias, lymphomas [Hodgkin, non-Hodgkin]; myelodysplastic syndrome) Secondary
7
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 7 Neutropenia Causes Prolonged severe infection Decreased production Reduced survival Abnormal neutrophil distribution and sequestration
8
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 8 Granulocytopenia (Agranulocytosis) Causes Interference with hematopoiesis Immune mechanisms Chemotherapy destruction Ionizing radiation Sepsis caused by agranulocytosis often results in death within 3 to 6 days
9
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 9 Eosinophilia Hypersensitivity reactions trigger the release of eosinophilic chemotactic factor of anaphylaxis from mast cells Increased in allergic disorders Increased in parasitic invasions
10
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 10 Eosinopenia Decrease in circulation numbers of eosinophils Usually caused by migration of cells to inflammatory sites Other causes Surgery, shock, trauma, burns, or mental distress
11
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 11 Basophils Basophils account for only up to 1% of the circulating WBCs Basophilia Response to inflammation and hypersensitivity reactions Basopenia Occurs in acute infections, hyperthyroidism, and long-term steroid therapy
12
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 12 Monocytes Monocytosis Poor correlation with disease Usually occurs with neutropenia in later stages of infections Monocytes are needed to phagocytize organisms and debris Monocytopenia Very little known about this condition Prednisone treatments Prednisone treatments Hairy cell leukemia Hairy cell leukemia
13
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 13 Lymphocytes Lymphocytosis Acute viral infections Epstein-Barr virus Epstein-Barr virus Lymphocytopenia Immune deficiencies, drug destruction, viral destruction
14
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 14 Infectious Mononucleosis (IM) Acute, self-limiting infection of B lymphocytes transmitted by saliva through personal contact Commonly caused by the Epstein-Barr virus (EBV)—85% B cells have an EBV receptor site Others viral agents resembling IM Cytomegalovirus (CMV), hepatitis, influenza, HIV Cytomegalovirus (CMV), hepatitis, influenza, HIV
15
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 15 Infectious Mononucleosis Symptoms: fever, sore throat, swollen cervical lymph nodes, increased lymphocyte count, and atypical (activated) lymphocytes; may affect multiple systems Serious complications are infrequent (<5%) Splenic rupture is the most common cause of death Lab values: >50% lymphocytes and at least 10% atypical lymphocytes Diagnostic test Monospot qualitative test for heterophilic antibodies Treatment: symptomatic
16
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 16 Leukemias Malignant disorder of the blood and blood- forming organs Uncontrolled proliferation of malignant leukocytes Overcrowding of bone marrow Decreased production and function of normal hematopoietic cells
17
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 17 Leukemias Acute leukemia Presence of undifferentiated or immature cells, usually blast cells Rapid onset with short survival Chronic leukemia Predominant cell is mature but does not function normally Slow progression
18
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 18 Leukemias Acute lymphocytic leukemia (ALL) Least common overall but most common childhood leukemia (80%) Acute myelogenous leukemia (AML) Most common adult leukemia (mean age, 67)
19
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 19 Leukemias Chronic myelogenous leukemia (CML) Usually diagnosed in adults Chronic lymphocytic leukemia (CLL) Common in adults (70% asymptomatic at diagnosis) Lymphadenopathy Lymphadenopathy Suppression of humoral immunity Suppression of humoral immunity Increased infection with encapsulated bacteria Increased infection with encapsulated bacteria
20
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 20 Leukemias Signs and symptoms of leukemias Anemia, bleeding purpura, petechiae, ecchymosis, thrombosis, hemorrhage, DIC, infection, weight loss, bone pain, elevated uric acid, and liver, spleen, and lymph node enlargement Clonal disorder in that a single progenitor cell undergoes malignant transformation
21
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 21 Lymphadenopathy Enlarged lymph nodes that become palpable and tender Local lymphadenopathy Drainage of an inflammatory lesion located near the enlarged node General lymphadenopathy Occurs in the presence of malignant or nonmalignant disease
22
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 22 Lymphadenopathy Causes Neoplastic disease Immunologic or inflammatory conditions Endocrine disorders Lipid storage diseases
23
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 23 Lymphadenopathy
24
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 24 Malignant Lymphomas Malignant transformation of a lymphocyte and proliferation of lymphocytes, histiocytes, their precursors, and derivatives in lymphoid tissues Two major categories Hodgkin lymphoma Linked to EBV Linked to EBV Non-Hodgkin lymphoma Lymphoblastic lymphoma
25
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 25 Hodgkin Lymphoma Reed-Sternberg cells in the lymph nodes These cells necessary for diagnosis, but not specific to Hodgkin lymphoma Classical Hodgkin lymphoma Nodular lymphocyte predominant Hodgkin lymphoma B cell in the germinal center that has not undergone successful immunoglobulin gene rearrangement but has undergone apoptosis
26
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 26 Hodgkin Lymphoma Physical findings Adenopathy, mediastinal mass, splenomegaly, and abdominal mass Symptoms Fever, weight loss, night sweats, pruritus Laboratory findings Thrombocytosis, leukocytosis, eosinophilia, elevated erythrocyte sedimentation rate (ESR), elevated alkaline phosphatase Paraneoplastic syndromes
27
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 27 Hodgkin Lymphoma
28
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 28 Hodgkin Lymphoma
29
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 29 Non-Hodgkin Lymphoma Generic term for diverse group of lymphomas The lymphomas can be differentiated based on etiology, unique features, and response to therapies Non-Hodgkin lymphomas are linked to chromosome translocations, viral and bacterial infections, environmental agents, immunodeficiencies, and autoimmune disorders
30
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 30 Non-Hodgkin Lymphoma Clonal expansion of B cells (85%), T cells, and/or NK cells Changes in proto-oncogenes and tumor- suppressor genes contribute to cell immortality and thus an increase in malignant cells
31
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 31 Burkitt Lymphoma Most common type of non-Hodgkin lymphoma in children A very fast-growing tumor of the jaw and facial bones Epstein-Barr virus is found in nasopharyngeal secretions of individuals
32
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 32 Burkitt Lymphoma
33
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 33 Plasma Cell Malignancies Multiple Myeloma Waldenström
34
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 34 Multiple Myeloma Proliferation of plasma cells The tumor may be solitary or multifocal (multiple myeloma) The malignant plasma cells produce abnormally large amounts of one class of immunoglobulin or incomplete immunoglobulin The unattached light chains of the immunoglobulins (Bence Jones proteins) can pass through the glomerulus and damage the renal tubular cells
35
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 35 Multiple Myeloma Increased osteoclastic bone destruction Hypercalcemia (13%), renal failure (19%), anemia (72%), bone lesions (80%) Clinical manifestations Cortical and medullary bone loss Skeletal pain Recurring infections due to loss of the humoral immune response
36
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 36 Alterations in Splenic Function Splenomegaly Hypersplenism Congestive splenomegaly Infiltrative splenomegaly Removal of the spleen Increased WBCs and platelets RBC abnormalities
37
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 37 Disorders of Platelets Thrombocytopenia Platelet count <100,000/mm 3 <50,000/mm 3 —hemorrhage from minor trauma <50,000/mm 3 —hemorrhage from minor trauma <15,000/mm 3 —spontaneous bleeding <15,000/mm 3 —spontaneous bleeding <10,000/mm 3 —severe bleeding <10,000/mm 3 —severe bleeding Causes: Hypersplenism, autoimmune disease, hypothermia, and viral or bacterial infections that cause DIC Hypersplenism, autoimmune disease, hypothermia, and viral or bacterial infections that cause DIC
38
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 38 Disorders of Platelets Immune thrombocytopenic purpura (ITP) IgG antibody targets platelet glycoproteins Antibody-coated platelets are sequestered and removed from the circulation Acute form develops after viral infections One of the most common childhood bleeding disorders One of the most common childhood bleeding disorders Manifestations Petechiae and purpura, progressing to major hemorrhage Petechiae and purpura, progressing to major hemorrhage
39
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 39 Disorders of Platelets Thrombotic thrombocytopenic purpura (TTP) A thrombotic microangiopathy Platelets aggregate, form microthrombi, and cause occlusion of arterioles and capillaries Platelets aggregate, form microthrombi, and cause occlusion of arterioles and capillaries Chronic relapsing TTP Acute idiopathic TTP
40
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 40 Disorders of Platelets Essential (primary) thrombocythemia Thrombocythemia is characterized by platelet counts >600,000/mm 3 Myeloproliferative disorder of platelet precursor cells Megakaryocytes in the bone marrow are produced in excess Megakaryocytes in the bone marrow are produced in excess Microvasculature thrombosis occurs
41
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 41 Alterations of Platelet Function Qualitative alterations demonstrate an increased bleeding time in the presence of a normal platelet count Disorders result from platelet membrane glycoprotein and von Willebrand factor deficiencies Manifestations Petechiae, purpura, mucosal bleeding, gingival bleeding, and spontaneous bruising Disorders can be congenital or acquired
42
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 42 Alterations of Coagulation Vitamin K deficiency Vitamin K is necessary for synthesis and regulation of prothrombin, the prothrombin factors (II, VII, XI, X), and proteins C and S (anticoagulants) Liver disease Causes broad range of hemostasis disorders Defects in coagulation, fibrinolysis, and platelet number and function Defects in coagulation, fibrinolysis, and platelet number and function
43
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 43 Disseminated Intravascular Coagulation (DIC) Complex, acquired disorder: clotting and hemorrhage simultaneously occur Sepsis, cancer, trauma, blood transfusion Result of increased protease activity in the blood caused by unregulated release of thrombin with subsequent fibrin formation and accelerated fibrinolysis Endothelial damage is primary initiator
44
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 44 Disseminated Intravascular Coagulation (DIC) Blockage of blood flow to organs, resulting in multiple organ failure Magnitude of clotting may result in consumption of platelets and clotting factors, leading to severe bleeding
45
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 45 Disseminated Intravascular Coagulation (DIC) The amount of activated thrombin exceeds the body’s antithrombins and the thrombin does not remain localized The widespread thromboses created cause widespread ischemia, infarction, and organ hypoperfusion
46
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 46 Disseminated Intravascular Coagulation (DIC) By activating the fibrinolytic system (plasmin), person’s fibrin degradation product and D -dimer levels increase Due to the person’s clinical state, the disorder has a high mortality rate Treatment is to remove the stimulus
47
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 47 Disseminated Intravascular Coagulation (DIC) Clinical signs and symptoms demonstrate wide variability Bleeding from venipuncture sites Bleeding from arterial lines Purpura, petechiae, and hematomas Symmetric cyanosis of the fingers and toes
48
Mosby items and derived items © 2010, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. 48 Thromboembolic Disease Arterial thrombi Defects in proteins involved in hemostasis Venous thrombi Variety of clinical disorders or conditions Hypercoagulabilty (thrombophilia) Acquired Mutations in coagulation proteins, fibrinolytic proteins, platelet receptors Triad of Virchow
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.